Accessibility settings

Published on in Vol 15 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/89819, first published .
Young boy plays with a large green leaf in a shallow, clear forest stream

Mapping Prevalence, Diagnostics, and Evidence Gaps of Cryptosporidium in Southeast Asia Across Human, Animal, and Environmental Domains: Protocol for a One Health Scoping Review

Mapping Prevalence, Diagnostics, and Evidence Gaps of Cryptosporidium in Southeast Asia Across Human, Animal, and Environmental Domains: Protocol for a One Health Scoping Review

Authors of this article:

Elad I Stotland1 Author Orcid Image ;   John Barlow1 Author Orcid Image ;   Andrea J Etter2 Author Orcid Image

1Department of Animal and Veterinary Sciences, College of Agriculture and Life Sciences, University of Vermont, Burlington, VT, United States

2Department of Nutrition and Food Sciences, College of Agriculture and Life Sciences, University of Vermont, 353 MLS Carrigan Wing, 109 Carrigan Drive, Burlington, VT, United States

*these authors contributed equally

Corresponding Author:

Andrea J Etter, PhD


Background: Cryptosporidium is a waterborne and zoonotic protozoan parasite that causes cryptosporidiosis, a diarrheal disease that disproportionately affects young children and immunocompromised individuals in low- and middle-income settings. In Southeast Asia, ecological diversity, agricultural intensification, and uneven sanitation infrastructure create overlapping transmission pathways across human, animal, and environmental domains. Despite a growing body of regional literature, the structure of the evidence base and its utility for surveillance and control have not been comprehensively evaluated using an integrated One Health lens.

Objective: This protocol outlines the methodology for a scoping review mapping the published literature on Cryptosporidium in Southeast Asia, characterizing the distribution of evidence on prevalence, diagnostic methods, species and genotype diversity, and environmental, food-related, and socioeconomic determinants of transmission across human, animal, and environmental domains.

Methods: The review follows the Arksey and O’Malley framework, refined by Levac and colleagues and the Joanna Briggs Institute, and is reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews (PRISMA-ScR). Five databases were searched from inception through September 30, 2024: PubMed, Embase, CABI Digital Library, Cochrane Library, and Index Medicus for the South-East Asia Region (IMSEAR), supplemented by backward citation tracking and targeted searches of organizational websites. Studies were included if they reported primary data on Cryptosporidium in human, animal, or environmental samples collected from one or more of the eleven Southeast Asian countries and addressed prevalence, diagnostic methods, or transmission risk factors. Reviews, editorials, letters, conference abstracts, and non-English publications were excluded. No formal risk-of-bias assessment was conducted, consistent with scoping review methodology. Data were organized thematically and synthesized descriptively, with findings presented across One Health domains using tables, figures, and maps generated in RStudio (version 2023.09.1+494).

Results: Database searches retrieved 889 records before deduplication. After removing 177 duplicates, 711 unique records underwent title and abstract screening. Of 333 full-text articles assessed for eligibility, 176 studies were included in the final synthesis, representing nine of eleven Southeast Asian countries and spanning 1985 to 2024. Data extraction and analysis are complete. The manuscript reporting the full findings is being prepared for submission to a peer-reviewed journal.

Conclusions: This scoping review provides a comprehensive cross-domain mapping of evidence on Cryptosporidium in Southeast Asia. The findings are expected to identify structural gaps in the regional evidence base, characterize diagnostic heterogeneity and its implications for surveillance utility, and support the development of integrated One Health surveillance strategies in the region.

Trial Registration: OSF Registries osf.io/qv27y; https://osf.io/qv27y/overview

International Registered Report Identifier (IRRID): DERR1-10.2196/89819

JMIR Res Protoc 2026;15:e89819

doi:10.2196/89819

Keywords



Cryptosporidium is an apicomplexan protozoan parasite of global public health importance that causes cryptosporidiosis, a diarrheal disease that primarily affects young children, immunocompromised individuals, and populations with limited access to safe water and sanitation [1-3]. The parasite spreads via the fecal-oral route, with oocysts shed by infected humans and animals contaminating water, food, and the environment, where they persist because they resist standard chlorine disinfection [1,2,4]. The Global Enteric Multicenter Study (GEMs) identified Cryptosporidium as one of the four leading causes of moderate-to-severe diarrhea among children under five in low- and middle-income countries. Subsequent analyses estimated that approximately 202,000 deaths annually are attributable to cryptosporidiosis worldwide [5-7]. Worldwide, Cryptosporidium accounts for most protozoan-related waterborne outbreaks, with more than 1200 incidents recorded between 2004 and 2016 [8,9].

Effective control of Cryptosporidium requires identifying the transmission source—contaminated water, infected animals, or human-to-human spread—because each pathway requires a different intervention [1,2]. At least 40 species are recognized, infecting a broad range of vertebrate hosts: C. hominis and C. parvum account for over 90% of human infections globally. C. parvum circulates among livestock, wildlife, and humans; contaminated water and food serve as transmission bridges between animal reservoirs and human populations [10,11]. Yet, most Cryptosporidium research has been conducted in disciplinary silos—human clinical studies, veterinary surveys, and environmental monitoring are rarely integrated within a single investigative framework—leaving the relative contribution of each transmission pathway empirically uncharacterized in most settings [1,2]. Addressing this complexity requires a One Health approach, which recognizes that human, animal, and environmental health are interdependent and that effective disease prevention requires integrated, multisectoral surveillance and intervention [1,12].

Southeast Asia is a high-priority region for this problem. The region comprises eleven countries with highly variable ecological conditions, agricultural systems, and public health infrastructure, united by rapid economic development, expanding smallholder livestock production, and persistent inequalities in access to water and sanitation [12,13]. These conditions create overlapping exposure pathways—contaminated surface water used for irrigation and drinking, close human-animal contact in peridomestic and farm settings, and consumption of raw or minimally processed produce—that cannot be adequately characterized by studies examining any single exposure domain [1,4]. Numerous studies have documented Cryptosporidium prevalence in human populations, including children [14,15], individuals living with HIV/AIDS [16,17], and rural communities [18,19], as well as in livestock [20,21], companion animals [22,23], and wildlife [24], underscoring the parasite’s zoonotic potential. Environmental sampling has further revealed contamination of surface water, wastewater, and food sources [25-27], indicating that the environment plays a role in sustaining transmission cycles across the region. A recent review identified Southeast Asia as the Asian subregion of highest Cryptosporidium concern across human, water, and food sources, yet that analysis was limited to quantitative outcomes and did not examine diagnostic heterogeneity, species distribution, evidence on risk factors, or One Health integration across the regional literature [28]. The evidence base needed to act on that concern does not currently exist in usable form.

Despite the volume of regional literature, three structural features prevent the translation of available data into surveillance and control decisions. First, diagnostic heterogeneity is pervasive; microscopy-only studies, which cannot distinguish Cryptosporidium species or identify transmission sources, remain common across the region, and genotyping-based studies are not epidemiologically comparable to microscopy-only studies, yet both are routinely aggregated in regional analyses [28,29]. Second, geographic coverage is severely uneven, with research concentrated in a small number of countries, leaving most of the region’s epidemiological profile uncharacterized [13,28]. Third, cross-domain integration is rare; most studies examine a single host population in isolation, making it impossible to trace transmission pathways across the human-animal-environment interface that defines risk in smallholder agricultural settings [1,28]. Together, these features suggest that the current literature may be insufficient to support zoonotic attribution, environmental source prioritization, or risk-based intervention targeting across Southeast Asia — a question this review is designed to address systematically.

This scoping review protocol addresses these gaps by systematically mapping the published literature on Cryptosporidium from Southeast Asia across human, animal, and environmental domains. The review is guided by the following research questions: (1) What is the reported prevalence of Cryptosporidium across human, animal, and environmental domains in Southeast Asian countries? (2) What diagnostic methods have been used in the regional literature, and how does diagnostic heterogeneity affect species-level resolution and transmission inference? (3) To what extent do studies integrate evidence across human, animal, and environmental domains within a One Health framework? (4) What environmental, food-related, and socioeconomic risk factors have been quantitatively assessed in association with Cryptosporidium infection or detection in the region?


Study Design and Framework

This scoping review follows the methodological framework proposed by Arksey and O’Malley [30], with enhancements by Levac et al [31], and guidance from the Joanna Briggs Institute (JBI) [32]. Reporting adheres to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews (PRISMA-ScR) [33], and the search strategy is reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Reporting of Systematic Searches (PRISMA-S) [34]. The completed PRISMA-ScR checklist is provided as a supplementary file. The protocol was registered prospectively on the Open Science Framework (osf.io/qv27y)

Objectives

This review aimed to map the existing literature on Cryptosporidium in Southeast Asia and was guided by the following research questions: (1) What is the reported prevalence of Cryptosporidium across human, animal, and environmental domains in Southeast Asian countries? (2) What diagnostic methods have been used across the regional literature, and how does diagnostic heterogeneity affect species-level resolution and transmission inference? (3) To what extent do studies integrate evidence across human, animal, and environmental domains within a One Health framework? (4) What environmental, food-related, and socioeconomic risk factors have been quantitatively assessed in association with Cryptosporidium infection or detection in the region?

Eligibility Criteria

Studies were included if they reported primary data on Cryptosporidium in human or animal populations within one or more of the 11 Southeast Asian countries: Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, the Philippines, Singapore, Thailand, Timor-Leste, and Vietnam. Eligible studies had to provide information on prevalence, diagnostic methods, or risk factors related to environmental, food, or socioeconomic domains. Only English-language publications were considered.

Studies were excluded if they were not primary research (eg, reviews, editorials, letters, or conference abstracts), were conducted outside the defined geographic region, or did not report on Cryptosporidium in human, animal, or environmental samples.

Information Sources and Search Strategy

We searched five databases: PubMed, Embase, CABI Digital Library, Cochrane Library, and Index Medicus for the South-East Asia Region (IMSEAR). The strategy combined organism-specific terms (eg, “Cryptosporidium,” “Cryptosporidiosis,” “C. parvum,” “C. hominis”) with geographic terms (eg, country names and “Southeast Asia,” “ASEAN”). Searches were designed to maximize inclusivity and minimize missed studies. Full search strategies for each database are provided in Multimedia Appendix 1, reported in accordance with PRISMA-S [34].

Backward citation tracking was performed by reviewing reference lists of included studies and relevant reviews. Targeted searches of organizational websites (eg. World Health Organization, WHO, Food and Agriculture Organization of the United Nations, FAO) were also conducted. No formal gray literature search was performed.

Screening and Selection Process

All search results were imported into EndNote 21 (Clarivate, Philadelphia, PA) for deduplication. Title and abstract screening, followed by full-text review, was conducted in the Covidence Systematic Review Software (Veritas Health Innovation, Melbourne, Australia) using predefined inclusion and exclusion criteria. Each article was independently screened by two reviewers, with discrepancies resolved by a third reviewer.

Data Extraction

Data extraction was performed by a single reviewer using a standardized form developed in Covidence. Due to the large number of included studies, dual extraction was not feasible within a reasonable timeframe. To ensure consistency, the form was piloted on ten records, revised based on identified inconsistencies, and the ten piloted records were re-extracted in full before proceeding with the remainder of the dataset. Extracted variables included study metadata (authors, year, country), study design and setting, host population (human, animal, environmental, or mixed), sample type and size, diagnostic methods, species/genotypes, prevalence, study limitations, and reported environmental, food-related, and socioeconomic risk factors. The data dictionary is provided in Multimedia Appendix 2 and is available through OSF (Open Science Framework).

Data Synthesis

A descriptive synthesis will summarize findings across the included studies. Data will be organized thematically across four domains corresponding to the research questions outlined above: prevalence distribution, diagnostic methods and species resolution, One Health domain integration, and transmission risk factors. Findings will be presented in tables, charts, and maps to illustrate trends in publication volume, geographic distribution, diagnostic approaches, prevalence estimates, species and genotype distribution, and associated risk factors. Descriptive statistics and visualizations will be generated using RStudio (version 2023.09.1+494; R Foundation for Statistical Computing).

Findings will be interpreted with attention to the One Health domain from which data were derived. Prevalence estimates from human, animal, and environmental studies reflect structurally different sampling frames and diagnostic contexts and will not be aggregated across domains. Studies using microscopy-only methods and those using genotyping-based methods yield epidemiologically non-comparable outputs and will be analyzed and presented separately where relevant, as species-level identification is required to distinguish anthroponotic from zoonotic transmission pathways.

No meta-analysis will be conducted. The heterogeneity of diagnostic methods, study populations, and case definitions across the included literature precludes meaningful pooling of prevalence estimates, and formal quantitative synthesis is inconsistent with scoping review methodology as outlined by the Joanna Briggs Institute [32]. No formal risk-of-bias assessment will be performed, consistent with the scoping review methodology.

Ethics and Dissemination

Results will be disseminated through a peer-reviewed publication targeting journals in the fields of neglected tropical diseases and parasitology. All extracted data and synthesis outputs will be made available in CSV format on the OSF project page [35] in accordance with FAIR (Findable, Accessible, Interoperable, Reusable) principles. No embargo is planned.


Database searches were conducted from February to September 2024, with the final search completed on September 30, 2024. A total of 889 records were retrieved across five databases prior to deduplication. Following the removal of 177 duplicates, 711 unique records underwent title and abstract screening. Of 333 full-text articles assessed for eligibility, 176 studies were included in the final synthesis, representing nine of eleven Southeast Asian countries and spanning the years 1985 to 2024. Brunei and Timor-Leste had no indexed studies identified in any of the databases searched.

Data extraction and descriptive analysis are complete. The manuscript reporting full findings is in preparation for submission to a peer-reviewed journal.


Principal Findings

This scoping review will provide a comprehensive synthesis of literature on Cryptosporidium in Southeast Asia, mapping research across human, animal, and environmental domains. It will identify geographic and thematic gaps, examine diagnostic practices, and assess the degree of One Health integration. These anticipated findings would extend prior regional syntheses that identified Southeast Asia as a high-priority context for Cryptosporidium burden but did not examine diagnostic heterogeneity, One Health integration, or surveillance utility across the regional literature [13,28].

Special attention will be given to diagnostic diversity, including reliance on microscopy versus molecular techniques such as polymerase chain reaction and sequencing, which enables species- and genotype-level identification critical for understanding zoonotic potential. The review will also characterize environmental surveillance efforts, including studies on water and food contamination, and highlight gaps in monitoring systems.

Findings will inform research priorities, support integrated surveillance strategies, and encourage multidisciplinary collaboration under the One Health framework. All extracted data and synthesis outputs will be shared publicly on the OSF in accordance with FAIR principles, ensuring transparency and enabling future meta-analyses and regional comparisons.

Strengths of this review include the pre-registered search strategy, dual-reviewer screening, and cross-domain scope encompassing human, animal, and environmental studies within a single synthesis. Limitations include restriction to English-language publications and single-reviewer data extraction, the latter mitigated by use of a structured extraction form piloted on ten records before full extraction.

Conclusion

This scoping review will provide a systematic, cross-domain evidence base to support more coordinated and interdisciplinary research on Cryptosporidium in Southeast Asia. The findings aim to inform future surveillance strategies, strengthen regional capacity for zoonotic disease prevention, and advance One Health approaches that address the complex drivers of transmission. Ultimately, this work supports the development of context-specific interventions and contributes to broader efforts in health systems resilience.

Acknowledgments

We thank Lauren Bowling, Chelsey Patch, Katalin Larsen, and Eurydice Aboagye for their support during the development of this protocol. Special thanks to Gary Atwood at the University of Vermont, Larner College of Medicine, Dana Health Sciences Library for guidance on the search strategy and Covidence.

AI Disclosure:

The authors used Grammarly (Grammarly Inc.) for language editing assistance. No other generative artificial intelligence tools were used in the preparation of this manuscript.

Funding

This study received no specific funding from any public, commercial, or not-for-profit funding agencies

Data Availability

All extracted data and synthesis outputs will be made available in CSV format on the OSF project page [35]. No embargo is planned. Data will be shared in accordance with FAIR (Findable, Accessible, Interoperable, Reusable) principles.

Authors' Contributions

Conceptualization: EIS

Data curation: EIS

Formal analysis: EIS

Methodology: EIS

Project administration: AJE

Supervision: AJE, JB

Writing - original draft: EIS

Writing – Review & Editing: AJE, JB

Conflicts of Interest

None declared.

Multimedia Appendix 1

Search strategy.

DOCX File, 21 KB

Multimedia Appendix 2

Data dictionary.

DOCX File, 15 KB

Checklist 1

PRISMA-S checklist.

DOCX File, 17 KB

Checklist 2

PRISMA-ScR checklist.

DOCX File, 53 KB

  1. Innes EA, Chalmers RM, Wells B, Pawlowic MC. A One Health approach to tackle Cryptosporidiosis. Trends Parasitol. Mar 2020;36(3):290-303. [CrossRef] [Medline]
  2. Checkley W, White AC Jr, Jaganath D, et al. A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium. Lancet Infect Dis. Jan 2015;15(1):85-94. [CrossRef] [Medline]
  3. Ali M, Ji Y, Xu C, Hina Q, Javed U, Li K. Food and waterborne Cryptosporidiosis from a One Health perspective: a comprehensive review. Animals (Basel). Nov 14, 2024;14(22):3287. [CrossRef] [Medline]
  4. Golomazou E, Mamedova S, Eslahi AV, Karanis P. Cryptosporidium and agriculture: a review. Sci Total Environ. Mar 15, 2024;916:170057. [CrossRef] [Medline]
  5. Kotloff KL, Nataro JP, Blackwelder WC, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet. Jul 20, 2013;382(9888):209-222. [CrossRef] [Medline]
  6. Liu J, Platts-Mills JA, Juma J, et al. Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study. The Lancet. Sep 2016;388(10051):1291-1301. [CrossRef]
  7. Troeger C, Blacker BF, Khalil IA, et al. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis. Nov 2018;18(11):1211-1228. [CrossRef]
  8. Baldursson S, Karanis P. Waterborne transmission of protozoan parasites: review of worldwide outbreaks – An update 2004–2010. Water Res. Dec 2011;45(20):6603-6614. [CrossRef]
  9. Efstratiou A, Ongerth JE, Karanis P. Waterborne transmission of protozoan parasites: review of worldwide outbreaks - An update 2011–2016. Water Res. May 2017;114:14-22. [CrossRef]
  10. Fayer R. Taxonomy and species delimitation in Cryptosporidium. Exp Parasitol. Jan 2010;124(1):90-97. [CrossRef] [Medline]
  11. Ryan U, Zahedi A, Feng Y, Xiao L. An update on Zoonotic Cryptosporidium species and genotypes in humans. Animals (Basel). Nov 19, 2021;11(11):3307. [CrossRef] [Medline]
  12. Lâm S, Dang-Xuan S, Unger F, et al. Operationalizing regional One Health initiatives in Southeast Asia: ways forward. One Health. Jun 2025;20:101034. [CrossRef] [Medline]
  13. Mahmoudi MR, Ongerth JE, Karanis P. Cryptosporidium and cryptosporidiosis: the Asian perspective. Int J Hyg Environ Health. Oct 2017;220(7):1098-1109. [CrossRef] [Medline]
  14. Al-Delaimy AK, Al-Mekhlafi HM, Nasr NA, et al. Epidemiology of intestinal polyparasitism among Orang Asli school children in rural Malaysia. PLoS Negl Trop Dis. Aug 2014;8(8):e3074. [CrossRef] [Medline]
  15. Aye T, Moe K, Nyein MM, Swe T. Cryptosporidiosis in Myanmar infants with acute diarrhea. Southeast Asian J Trop Med Public Health. Dec 1994;25(4):654-656. [Medline]
  16. Asma I, Johari S, Sim BLH, Lim YAL. How common is intestinal parasitism in HIV-infected patients in Malaysia? Trop Biomed. Aug 2011;28(2):400-410. [Medline]
  17. Chhin S, Harwell JI, Bell JD, et al. Etiology of chronic diarrhea in antiretroviral-naive patients with HIV infection admitted to Norodom Sihanouk Hospital, Phnom Penh, Cambodia. Clin Infect Dis. Oct 1, 2006;43(7):925-932. [CrossRef] [Medline]
  18. Claveria FG, Alonzo C, Bacal AM, Mayugba ZM. Survey of Cryptosporidium sp. infection in two impoverished communities in Metro Manila, Philippines. J Protozool Res. 2007;17(2):32-38. [CrossRef]
  19. Cross JH, Alcantara A, Alquiza L, Zaraspe G, Ranoa C. Cryptosporidiosis in Philippine children. Southeast Asian J Trop Med Public Health. Jun 1985;16(2):257-260. [Medline]
  20. Afzan Mat Yusof AM, Muhammad Lokman MD. Prevalence and molecular characterisation of Cryptosporidium from dairy cattle in five farms in Kuantan. Malay Appl Biol J. 2017;46(2):21-27. URL: https://www.mabjournal.com/images/46_2_June_2017/46_02_03.pdf [Accessed 2024-08-28]
  21. Abdullah DA, Ola-Fadunsin SD, Ruviniyia K, et al. Molecular detection and epidemiological risk factors associated with Cryptosporidium infection among cattle in Peninsular Malaysia. Food Waterborne Parasitol. Mar 2019;14:e00035. [CrossRef] [Medline]
  22. Inpankaew T, Traub R, Thompson RCA, Sukthana Y. Canine parasitic zoonoses in Bangkok temples. Southeast Asian J Trop Med Public Health. Mar 2007;38(2):247-255. [Medline]
  23. Tangtrongsup S, Scorza AV, Reif JS, Ballweber LR, Lappin MR, Salman MD. Seasonal distributions and other risk factors for Giardia duodenalis and Cryptosporidium spp. infections in dogs and cats in Chiang Mai, Thailand. Prev Vet Med. Jan 2020;174:104820. [CrossRef] [Medline]
  24. Murakoshi F, Recuenco FC, Omatsu T, et al. Detection and molecular characterization of Cryptosporidium and Eimeria species in Philippine bats. Parasitol Res. May 2016;115(5):1863-1869. [CrossRef] [Medline]
  25. Azlan AM, Rasid MN, Richard RL, et al. Titiwangsa Lake a source of urban parasitic contamination. Trop Biomed. Sep 1, 2016;33(3):594-598. [Medline]
  26. Anh VT, Tram NT, Klank LT, Cam PD, Dalsgaard A. Faecal and protozoan parasite contamination of water spinach ( Ipomoea aquatica ) cultivated in urban wastewater in Phnom Penh, Cambodia. Tropical Med Int Health. Dec 2007;12(s2):73-81. [CrossRef]
  27. Azman J, Init I, Wan Yusoff WS. Occurrence of Giardia and Cryptosporidium (oo)cysts in the river water of two recreational areas in Selangor, Malaysia. Trop Biomed. Dec 2009;26(3):289-302. [Medline]
  28. Ahmed SAA, Boughattas S, Mahmoudi MR, et al. Cryptosporidium and cryptosporidiosis: an update of Asian perspectives in humans, water and food, 2015–2025. Curr Res Parasitol Vector-Borne Dis. 2025;8:100311. [CrossRef]
  29. Chalmers RM, Katzer F. Looking for Cryptosporidium: the application of advances in detection and diagnosis. Trends Parasitol. May 2013;29(5):237-251. [CrossRef] [Medline]
  30. Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. Feb 2005;8(1):19-32. [CrossRef]
  31. Levac D, Colquhoun H, O’Brien KK. Scoping studies: advancing the methodology. Implement Sci. Sep 20, 2010;5(1):69. [CrossRef] [Medline]
  32. Peters MDJ, Godfrey C, McInerney P, Munn Z, Tricco AC, Khalil H. Scoping reviews. In: Aromataris E, Munn Z, editors. JBI Manual for Evidence Synthesis. JBI; 2020. URL: https://jbi-global-wiki.refined.site/space/MANUAL/355862497/10.+Scoping+reviews [Accessed 2024-07-14]
  33. Tricco AC, Lillie E, Zarin W, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. Oct 2, 2018;169(7):467-473. [CrossRef] [Medline]
  34. Rethlefsen ML, Kirtley S, Waffenschmidt S, et al. PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews. Syst Rev. Jan 26, 2021;10(1):39. [CrossRef] [Medline]
  35. Cryptosporidium in Southeast Asia: scoping the literature on environmental and socioeconomic drivers of infection from a One Health Lens. OSF. URL: https://osf.io/qv27y/overview [Accessed 2026-06-10]


ASEAN: Association of Southeast Asian Nations
FAIR: Findable, Accessible, Interoperable, Reusable
FAO: Food and Agriculture Organization of the United Nations
GEMs: Global Enteric Multicenter Study
HIV/AIDS: Human Immunodeficiency Virus / Acquired Immunodeficiency Syndrome
IMSEAR: Index Medicus for the South-East Asia Region
OSF: Open Science Framework
PRISMA-S: Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Reporting of Systematic Searches
PRISMA-ScR: Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews
WHO: World Health Organization


Edited by Amy Schwartz; submitted 17.Dec.2025; peer-reviewed by Mo Salman; final revised version received 04.May.2026; accepted 18.May.2026; published 19.Jun.2026.

Copyright

© Elad I Stotland, John Barlow, Andrea J Etter. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 19.Jun.2026.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Research Protocols, is properly cited. The complete bibliographic information, a link to the original publication on https://www.researchprotocols.org, as well as this copyright and license information must be included.